(Q44512643)

3 December 2017

Lipopeptide adjuvants in combination treatment (English)

1 reference

3 December 2017

Wolfgang G Bessler

1

1 reference

3 December 2017

K Mittenbühler

series ordinal

2

1 reference

3 December 2017

U v d Esche

series ordinal

3

1 reference

3 December 2017

M Huber

series ordinal

4

1 reference

3 December 2017

1 August 2003

1 reference

International Immunopharmacology

3 December 2017

1 reference

3 December 2017

3

1 reference

3 December 2017

8

1 reference

3 December 2017

1217-1224

1 reference

Synthetic lipopeptides as novel adjuvants

3 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2803%2900027-4

7 January 2021

Generation of antibodies directed against the low-immunogenic peptide-toxins microcystin-LR/RR and nodularin

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2803%2900027-4

7 January 2021

Modulation of the Th1/Th2 bias by lipopeptide and saponin adjuvants in orally immunized mice

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2803%2900027-4

7 January 2021

Lipopeptides as immunoadjuvants and immunostimulants in mucosal immunization

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2803%2900027-4

7 January 2021

Induction of tumor cytotoxicity in murine bone marrow-derived macrophages by two synthetic lipopeptide analogues

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2803%2900027-4

7 January 2021

Enhancement of protection against Salmonella infection in mice mediated by a synthetic lipopeptide analogue of bacterial lipoprotein in S. typhimurium vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2803%2900027-4

7 January 2021

In vivo priming of virus-specific cytotoxic T lymphocytes with synthetic lipopeptide vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2803%2900027-4

7 January 2021

Efficiency of peptides and lipopeptides for in vivo priming of virus-specific cytotoxic T cells

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2803%2900027-4

7 January 2021

Activation of bone marrow-derived mouse macrophages by bacterial lipopeptide: cytokine production, phagocytosis and Ia expression.

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2803%2900027-4

7 January 2021

Immunostimulation by bacterial components: I. Activation Of macrophages and enhancement of genetic immunization by the lipopeptide P3CSK4.

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2803%2900027-4

7 January 2021

Cell activation and apoptosis by bacterial lipoproteins through toll-like receptor-2

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2803%2900027-4

7 January 2021

Cutting edge: preferentially the R-stereoisomer of the mycoplasmal lipopeptide macrophage-activating lipopeptide-2 activates immune cells through a toll-like receptor 2- and MyD88-dependent signaling pathway

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2803%2900027-4

7 January 2021

Histopathological studies on the local reactions induced by complete Freund's adjuvant (CFA), bacterial lipopolysaccharide (LPS), and synthetic lipopeptide (P3C) conjugates

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2803%2900027-4

7 January 2021

10.1016/S1567-5769(03)00027-4

Identifiers

DOI

1 reference

3 December 2017

1 reference